Basic info
Industry
biotechnology research
Sectors
Biotechnology
Health Diagnostics
KLH Protein (HMW and Subunit Formulations)
KLH-Based Active Immunotherapy development
Pharmaceutical
Keyhole Limpet Hemocyanin (KLH) manufacture & sales
KLH for Immunotoxicology & TDAR
KLH for Vaccine Conjugation & as Carrier Protein
Date founded
1999
Funding rounds raised
Total raised
$7M
from 3 investors over 3 rounds
S
Stellar Biotechnologies, Inc. raised $7M on September 20, 2017
Investors: Inveready, Lumira Ventures and Pharmascience